|3.28||-0.0600||-1.80%||Vol 827.85K||1Y Perf -21.58%|
|Apr 20th, 2021 16:00 DELAYED|
|- -||0.02 0.61%|
|Target Price||7.08||Analyst Rating||Strong Buy 1.00|
|Potential %||115.85||Finscreener Ranking||★★★★★ 66.71|
|Insiders Trans % 3/6/12 mo.||-100/-100/-100||Value Ranking||★★★★+ 60.65|
|Insiders Value % 3/6/12 mo.||-100/-100/-100||Growth Ranking||★★★★★ 79.50|
|Insiders Shares Cnt. % 3/6/12 mo.||-100/-100/-100||Income Ranking||— -|
|Market Cap||330.83M||Earnings Rating||Neutral|
|Price Range Ratio 52W %||9.96||Earnings Date||6th May 2021|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Sell|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||6th May 2021|
|Estimated EPS Next Report||0.07|
|EPS Growth Next 5 Years %||-|
|Avg. Weekly Volume||1.07M|
|Avg. Monthly Volume||1.09M|
|Avg. Quarterly Volume||1.19M|
BioDelivery Sciences International Inc. (NASDAQ: BDSI) stock closed at 3.28 per share at the end of the most recent trading day (a -1.8% change compared to the prior day closing price) with a volume of 827.89K shares and market capitalization of 330.83M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 178 people. BioDelivery Sciences International Inc. CEO is Jeffrey Allen Bailey.
The one-year performance of BioDelivery Sciences International Inc. stock is -21.58%, while year-to-date (YTD) performance is -21.9%. BDSI stock has a five-year performance of -11.11%. Its 52-week range is between 3.04 and 5.45, which gives BDSI stock a 52-week price range ratio of 9.96%
BioDelivery Sciences International Inc. currently has a PE ratio of 14.30, a price-to-book (PB) ratio of 3.19, a price-to-sale (PS) ratio of 2.85, a price to cashflow ratio of 14.40, a PEG ratio of 2.32, a ROA of 11.71%, a ROC of 14.05% and a ROE of 27.92%. The company’s profit margin is 17.72%, its EBITDA margin is 25.90%, and its revenue ttm is $118.19 Million , which makes it $1.17 revenue per share.
Of the last four earnings reports from BioDelivery Sciences International Inc., there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $0.07 for the next earnings report. BioDelivery Sciences International Inc.’s next earnings report date is 06th May 2021.
The consensus rating of Wall Street analysts for BioDelivery Sciences International Inc. is Strong Buy (1), with a target price of $7.08, which is +115.85% compared to the current price. The earnings rating for BioDelivery Sciences International Inc. stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
BioDelivery Sciences International Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
BioDelivery Sciences International Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 9.11, ATR14 : 0.20, CCI20 : -167.87, Chaikin Money Flow : -0.25, MACD : -0.22, Money Flow Index : 27.67, ROC : -14.58, RSI : 38.43, STOCH (14,3) : 7.35, STOCH RSI : 0.00, UO : 27.39, Williams %R : -92.65), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of BioDelivery Sciences International Inc. in the last 12-months were: Francis E. O'Donnell (Option Excercise at a value of $0), Francis E. O'Donnell (Sold 54 500 shares of value $244 325 ), Herm Cukier (Option Excercise at a value of $0), James Vollins (Option Excercise at a value of $187 692), James Vollins (Sold 63 627 shares of value $281 781 ), Jeffrey Allen Bailey (Option Excercise at a value of $0), Jeffrey Allen Bailey (Sold 10 000 shares of value $43 500 ), Kevin Kotler (Option Excercise at a value of $87 900), Mark A. Sirgo (Option Excercise at a value of $0), Mark A. Sirgo (Sold 800 000 shares of value $3 827 100 ), Mary Theresa Coelho (Option Excercise at a value of $0), Mary Theresa Coelho (Sold 9 922 shares of value $41 306 ), Scott Plesha (Option Excercise at a value of $0), Scott Plesha (Sold 15 000 shares of value $67 800 ), Thomas B. Smith (Option Excercise at a value of $0), Todd C. Davis (Option Excercise at a value of $0), Todd C. Davis (Sold 100 000 shares of value $499 000 ), Vanila Singh (Option Excercise at a value of $0), William Mark Watson (Option Excercise at a value of $0), William Mark Watson (Sold 26 000 shares of value $134 680 )
Copyright © 2016-2021 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
This could take some time, please wait.